| Akt | Protein Kinase B |
| ANOVA | Analysis of variance |
| CI | Confidence interval |
| CONSORT | Consolidated Standards of Reporting Trials |
| COX-2 | Cyclooxygenase enzyme-2 isoenzyme |
| CK | Creatine kinase |
| DMARDS | Disease-modifying antirheumatic drugs |
| GLM | General linear model |
| GMC-SF | Granulocyte-macrophage colony-stimulating factor |
| HDL | High-density lipoprotein |
| HOMAIR | Homeostatic model assessment for insulin resistance |
| IFN-γ | Interferon-γ |
| IL | Interleukin |
| LDL | Low-density lipoproteins |
| LSD | Least Significant Difference |
| NF-κβ | Nuclear Factor-kappa β |
| OTC | Over the counter |
| NSAIDS | Nonsteroidal anti-inflammatory drugs |
| QOL | Quality of life |
| ROM | Range of motion |
| SD | Standard deviation |
| SF-36 | Short Form Health Survey, 36-item |
| TNF-α | Tumor Necrosis Factor-α |
| TRPV1 | Vanilloid subtype 1 pain-sensitive receptor |
| VAS | Visual analog scale |
| VLDL | Very-low-density lipoprotein |
| WOMAC | Western Ontario and McMaster Universities Osteoarthritis Index |